tiprankstipranks
Advertisement
Advertisement

GRFS Stock Latest News

Grifols SA Signals Resilient Growth in Latest Earnings Call
Company AnnouncementsGrifols SA Signals Resilient Growth in Latest Earnings Call
22h ago
GRFS
Grifols Calls June 2026 Shareholders’ Meeting With Broad Capital and Governance Mandate
PremiumCompany Announcements
Grifols Calls June 2026 Shareholders’ Meeting With Broad Capital and Governance Mandate
5d ago
6K
GRFS
Grifols price target lowered to EUR 10 from EUR 11 at Deutsche Bank
PremiumThe Fly
Grifols price target lowered to EUR 10 from EUR 11 at Deutsche Bank
8d ago
GRFS
Grifols SA Signals Stable Margins, Strong IG Growth
PremiumCompany Announcements
Grifols SA Signals Stable Margins, Strong IG Growth
9d ago
GRFS
Grifols Lifts Q1 2026 Profit and Revenue as Immunoglobulins Surge and Debt is Refinanced
PremiumCompany Announcements
Grifols Lifts Q1 2026 Profit and Revenue as Immunoglobulins Surge and Debt is Refinanced
13d ago
6K
GRFS
Grifols reports Q1 adjusted EBITDA EUR 381M, up 0.8% cc
PremiumThe FlyGrifols reports Q1 adjusted EBITDA EUR 381M, up 0.8% cc
13d ago
GRFS
Grifols says Q1 results support FY26 guidance
Premium
The Fly
Grifols says Q1 results support FY26 guidance
13d ago
GRFS
GRFS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
GRFS Earnings this Week: How Will it Perform?
23d ago
GRFS
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
PremiumCompany Announcements
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
1M ago
6K
GRFS
New conditions imposed on Grifols by Health Canada, CBC News reports
PremiumThe Fly
New conditions imposed on Grifols by Health Canada, CBC News reports
2M ago
GRFS
Grifols rallies after board approves IPO of U.S. Biopharma business
PremiumThe Fly
Grifols rallies after board approves IPO of U.S. Biopharma business
2M ago
GRFS
Grifols Weighs U.S. IPO of Biopharma Subsidiary to Support Self-Sufficiency Strategy
PremiumCompany Announcements
Grifols Weighs U.S. IPO of Biopharma Subsidiary to Support Self-Sufficiency Strategy
2M ago
6K
GRFS
Grifols to evaluate potential IPO of U.S. Biopharma business
PremiumThe FlyGrifols to evaluate potential IPO of U.S. Biopharma business
2M ago
GRFS
Grifols price target lowered to EUR 11 from EUR 12 at Deutsche Bank
Premium
The Fly
Grifols price target lowered to EUR 11 from EUR 12 at Deutsche Bank
2M ago
GRFS
Grifols shares results of Chronos Platforms identifying early Parkinson’s
Premium
The Fly
Grifols shares results of Chronos Platforms identifying early Parkinson’s
2M ago
GRFS
Grifols downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
Grifols downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
GRFS
Grifols Doubles 2025 Profit and Secures Key Plasma and Fibrinogen Approvals
PremiumCompany Announcements
Grifols Doubles 2025 Profit and Secures Key Plasma and Fibrinogen Approvals
3M ago
6K
GRFS
Grifols Swings to Profit as Board Signs Off 2025 Annual Accounts
PremiumCompany Announcements
Grifols Swings to Profit as Board Signs Off 2025 Annual Accounts
3M ago
6K
GRFS
Grifols reports Q4 adjusted EBITDA EUR 467M, consensus EUR 469.7M
PremiumThe Fly
Grifols reports Q4 adjusted EBITDA EUR 467M, consensus EUR 469.7M
3M ago
GRFS
Grifols sees 2026 adjusted EBITDA growth 5%-9%
PremiumThe FlyGrifols sees 2026 adjusted EBITDA growth 5%-9%
3M ago
GRFS
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
GRFS
Grifols Adjusts Board Secretariat Roles Effective January 1, 2026
Premium
Company Announcements
Grifols Adjusts Board Secretariat Roles Effective January 1, 2026
4M ago
6K
GRFS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >